Learning Objectives: 

  1. Review the current literature on the clinical connections between COVID-19 and new-onset T1D/T2D.
  2. Characterize the effects of SARS-CoV-2 infection on pancreatic beta cells in vivo.
  3. Discuss the possible implications of this work to post-acute sequelae of COVID-19 (PASC).
Session date: 
03/28/2022 - 5:00pm to 6:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Senta K. Georgia, Ph.D.